BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2007
View Archived Issues
Vinorelbine-cisplatin confirmed superior in stage II-IIIA NSCLC / News in Context
Read More
Eisai: Q3 report
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
Recent Nissan Chemical patents describe new treatment options for thrombocytopenia
Read More
Axcan updates Q1 developments
Read More
ZymoGenetics' rhThrombin BLA accepted for review
Read More
SGX reviews oncology pipeline
Read More
Ark Therapeutics discusses phase III Vitor study with regulatory agencies
Read More
Valeant acquires rights to nabilone in the U.K. and Europe
Read More
KeyNeurotek and Max-Planck sign licensing agreement
Read More
Merck begins registrations of Atripla in developing countries
Read More
Inspire to commercialize AzaSite in U.S. and Canada
Read More
Gestiva reduces cervical shortening
Read More
Canarypox HIV vaccine responses in phase II not sufficient for phase III investigation
Read More
Pipex Pharmaceuticals' Coprexa awarded NIH grant for Alzheimer's disease
Read More
Post hoc subgroup analysis for Chrysalin in fracture repair
Read More
Safety, absorption of TMC-120 assessed in women with and without HIV
Read More
Traditional Chinese preparation to enter the clinic for the treatment of allergic asthma
Read More
New agents for treating neurological disorders disclosed in recent patents
Read More
Recent patents disclose novel treatments for diabetes
Read More
Cadherin-11: a potential target against rheumatoid arthritis
Read More
Cognitive and mood improvement after guarana therapy reported
Read More
